Lesser doses for perioral treatment than for upper facial applications are used given that the oral musculature responds additional strongly to the exact same BTX-A dosing. Only one planning of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indicator and FDA approval lies in treatments of cervical dystonia. The https://botulinum-toxins20627.bloggactif.com/36999478/facts-about-botulinum-toxin-vs-botox-revealed